Prognosis
In Fighting Outbreaks, Big Pharma Struggles to Get Out Front
- Sanofi partners with U.S. for coronavirus shot after Zika flop
- Glaxo tried to lead vaccine pandemic effort but failed
This article is for subscribers only.
Sanofi joined the race to combat the coronavirus as the outbreak kindles fears of a pandemic. The question is whether its effort will prove more effective than some of Big Pharma’s past attempts to tackle dangerous new pathogens.
The French drugmaker said Tuesday it will team up with a U.S. agency to develop a vaccine against the virus that has killed more than 1,800 people. Sanofi is betting its earlier work to develop a SARS vaccine will speed the effort.